APAF1 Silencing Ameliorates Diabetic Retinopathy by Suppressing Inflammation, Oxidative Stress, and Caspase-3/GSDME-Dependent Pyroptosis
Yuanyuan Ding,Linjiang Chen,Jing Xu,Yuhan Feng,Qiong Liu
DOI: https://doi.org/10.2147/dmso.s449049
2024-04-10
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yuanyuan Ding, &ast Linjiang Chen, &ast Jing Xu, Yuhan Feng, Qiong Liu Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiong Liu, Department of Ophthalmology, Nanfang Hospital, Southern Medical University, No. 1838, North Guangzhou Avenue, Baiyun District, Guangzhou, Guangdong Province, 510515, People's Republic of China, Tel +86-13922442109, Email Objective: Diabetic retinopathy (DR) can cause permanent blindness with unstated pathogenesis. We aim to find novel biomarkers and explore the mechanism of apoptotic protease activating factor 1 (APAF1) in DR. Methods: Differential expression genes (DEGs) were screened based on GSE60436 dataset to find hub genes involved in pyroptosis after comprehensive bioinformatics analysis. DR mice model was constructed by streptozotocin injection. The pathological structure of retina was observed using hematoxylin-eosin staining. The enzyme-linked immunosorbent assay was applied to assess inflammatory factors, vascular endothelial growth factor (VEGF), and oxidative stress. The mRNA and protein expression levels were detected using quantitative real-time polymerase-chain reaction and Western blot. Cell counting kit and flow cytometry were employed to detect proliferation and apoptosis in high glucose-induced ARPE-19 cells. Results: Total 71 pyroptosis-related DEGs were screened. BIRC2, CXCL8, APAF1, PPARG, TP53, and CYCS were identified as hub genes of DR. APAF1 was selected as a potential regulator of DR, which was up-regulated in DR mice. APAF1 silencing alleviated retinopathy and inhibited pyroptosis in DR mice with decreased levels of inflammatory factors, VEGF, and oxidative stress. Moreover, APAF1 silencing promoted proliferation while inhibiting apoptosis and caspase-3/GSDME-dependent pyroptosis with a decrease in TNF-α, IL-1β, IL-18, and lactate dehydrogenase in high glucose-induced ARPE-19 cells. Additionally, caspase-3 activator reversed the promotion effect on proliferation and inhibitory effect on apoptosis and pyroptosis after APAF1 silencing in high glucose-induced ARPE-19 cells. Conclusion: APAF1 is a novel biomarker for DR and APAF1 silencing inhibits the development of DR by suppressing caspase-3/GSDME-dependent pyroptosis. Keywords: diabetic retinopathy, APAF1, caspase-3, GSDME, pyroptosis The onset of diabetic retinopathy (DR) typically takes approximately 10 years after the diagnosis of diabetes for clinical manifestations to emerge, with an incidence rate ranging from 24.7% to 35.7%. 1 Microvascular complications of diabetes frequently occur in patients with DR, which is rapidly increasing globally. 2 DR consists of non-proliferative DR and proliferative DR, according to whether neovascularization occurs in retina. 3 DR can cause loss of peripheral cells, endothelial cell damage, and thickening of the basement membrane, which can lead to a breakdown of the blood-retinal barrier, blood vessel leakage, and insufficient oxygen supply to the retina, eventually inducing permanent blindness. 4–6 Current treatments for DR include anti-vascular drugs, laser photocoagulation, and vitrectomy. 7–9 Unfortunately, the efficacy of the current treatments is still significantly unsatisfactory. 10 Additionally, despite significant advances in retinal imaging in recent years, mild DR is a subtle symptom, which poses challenges for early diagnosis and subsequent intervention. 11 Therefore, there is an urgent need to find new diagnostic and therapeutic targets for DR. In addition to being essential to body growth, cell death preserves homeostasis and wards against disease. 12 Pyroptosis is a type of lytic programmed cell death, which is distinguished by enlargement of the cell followed by the discharge of proinflammatory factors like interleukin (IL)-1β and IL-18. 13 Pyroptosis depends on caspase-1 and its receptor, NOD-like receptor thermal protein domain associated protein 3 (NLRP3), which recognizes and activates the inactive caspase-1 to induce cell lysis, death, and the release of intracellular material through an incomplete cell membrane, causing an inflammatory response. 14 According to recent research, inflammation is a major factor in the etiology of DR. For instance, caspase-1 and NLRP3 in peripheral blood mononuclear cells of DR patients are increased than those of normal controls, and the concentrations of NLRP3, caspase-1, and the pro-inflammatory factor IL-1β/18 are significantly elevated in the vitreous body. 15 Studies have shown that chronic hyperglycemia induces Gasdermi -Abstract Truncated-
endocrinology & metabolism